US HB2483

Reauthorizes opioid use disorder prevention, treatment, and recovery programs through fiscal years 2026-2030, with funding increases including $505.6 million annually for overdose prevention, $57 million for first responder training, and $40 million for substance use disorder treatment workforce loan repayment

Establishes a comprehensive Fetal Alcohol Spectrum Disorders (FASD) prevention and services program with $12.5 million annually for education, research, screening, and support for affected individuals and families

Creates a Federal Interagency Work Group on Fentanyl Contamination of Illegal Drugs to coordinate federal efforts, educate youth about dangers, and reduce overdose deaths from fentanyl-contaminated substances

Strengthens cybersecurity protections for the 988 National Suicide Prevention Lifeline, requiring reporting of vulnerabilities and incidents, and mandates a GAO study on cybersecurity risks within 180 days

Expands treatment access by requiring HHS to review scheduling of buprenorphine-naloxone combination products, allowing pharmacies to deliver certain controlled substances to practitioners, and broadening prescriber training requirements to include podiatric medicine and additional professional organizations